遠隔医療（テレヘルス＆テレメディシン）市場 – 2030年までの世界予測

Report Overview

The telehealth and telemdicine market is projected to reach USD 180.86 billion by 2030 from USD 94.14 billion in 2024, at a CAGR of 11.5% from 2024 to 2030.

テレヘルス＆テレメディシン市場は、2024 年から 2030 年までの CAGR 11.5% で、2024 年の 941 億 4000 万米ドルから 2030 年までに 1,808 億 6000 万米ドルに達すると予測されています。

The telehealth and telemedicine market is rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, emphasizes the value of remote care.

テレヘルス＆テレメディシン市場は、通信技術の進歩、政府の支援と規制政策、遠隔患者監視システムの拡大などのさまざまな要因により急速に拡大しています。人口の高齢化により慢性疾患の継続的なモニタリングが必要となり、費用対効果の高い医療ソリューションに対する需要が高まっています。さらに、糖尿病や心血管疾患などの慢性疾患の有病率が上昇しているため、遠隔ケアの価値が強調されています。

Telemedicine saves a lot of time and money, hence becoming attractive for both patients and providers. The advancements in the field of telecommunications technology along with the increasing adoption of remote patient monitored technologies have enhanced the virtual care success rate and market adoption, while government support through favorable regulation and reimbursable frameworks has helped in market expansion.

“Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user.”

By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.

“By component, software segment to accounted for the largest market share in the telehealth and telemedicine market.”

Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is  accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.

“Asia Pacific is estimated to register the fastest CAGR over the forecast period.”

The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: Managers (40%), Directors (35%), and Others (25%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%) and Middle East & Africa (2%)

List of Companies Profiled in the Report:

• Koninklijke Philips N.V. (Netherlands)
• Medtronic (Ireland)
• GE Healthcare (US)
• Epic Systems Corporation (US)
• Oracle (US)
• Doximity, Inc. (US)
• Teladoc Health, Inc. (US)
• American Well (US)
• Siemens Healthineers AG (Germany)
• Cisco Systems Inc. (US)
• Included Health, Inc. (Doctor on Demand, Inc.) (US)
• AMC Health (US)
• TeleSpecialists (US)
• Walgreen Co. (US)
• Caregility (US)
• CVS Health (US)
• EverNorth Health, Inc. (US)
• Elation (US)
• Iron Bow Healthcare Solutions (US)
• ZoomCommunications, Inc. (US)
• Timedoc Health (US)
• Cerebral Inc. (US)
• Kindbody (US)
• Transcarent (US)
• Caresimple, Inc. (US)

Research Coverage:

This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease,  Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers),      Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers: (Growing geriatric population and increasing need to expand healthcare access, Rising prevalence of chronic conditions, Demonstrated Time and Cost Savings, Advancements in telecommunication technologies, Shortage of skilled healthcare professionals, Government support & Regulatory policies, Expansion of Remote Patient Monitoring (RPM) systems), restraints (High investment costs and lack of IT expertise, Regulatory variations across regions, Behavioral reluctance to adopt new technologies, Rise in fraud and abuse within healthcare systems, Patient privacy and confidentiality, adhering to medical ethics), opportunities (Growing use of wearables, apps, and sensors for virtual care, Emergence of AI/ML, Increasing shift towards outpatient care models, High utility of telemedicine against infectious diseases and epidemics, Expansion of hospital-at-home initiatives, Demand for EMR-based telehealth, Rapid growth of mental health care), and challenges (Data security concerns, Limited data accessibility, Inability to maintain hygiene and cleanliness standards) influencing the growth of the telehealth & telemedicine market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth & telemedicine market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the telehealth & telemedicine market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth & telemedicine market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc. among others in telehealth & telemedicine market.

Table of Contents

1               INTRODUCTION              43

1.1           STUDY OBJECTIVES       43

1.2           MARKET DEFINITION   43

1.2.1        TELEHEALTH    43

1.2.2        TELEMEDICINE 43

1.3           STUDY SCOPE   44

1.3.1        MARKET SEGMENTATION & GEOGRAPHICAL SPREAD                 44

1.3.2        INCLUSIONS & EXCLUSIONS       45

1.3.3        YEARS CONSIDERED      47

1.3.4        CURRENCY CONSIDERED            47

1.4           STAKEHOLDERS               47

1.5           SUMMARY OF CHANGES               48

2               RESEARCH METHODOLOGY       50

2.1           RESEARCH DATA              50

2.1.1        SECONDARY DATA          51

2.1.1.1    Key sources of secondary data            51

2.1.1.2    Key data from secondary sources       52

2.1.2        PRIMARY DATA 52

2.1.2.1    Key sources of primary data                53

2.1.2.2    Key objectives of primary research    53

2.1.2.3    Key data from primary sources           54

2.1.2.4    Insights from primary experts             55

2.2           RESEARCH APPROACH  56

2.3           MARKET SIZE ESTIMATION         56

2.3.1        REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS)                 57

2.3.2        BOTTOM-UP APPROACH (END-USER ADOPTION)                 58

2.3.3        TOP-DOWN APPROACH                59

2.3.4        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      60

2.4           DATA TRIANGULATION                63

2.5           MARKET SHARE ESTIMATION    64

2.6           STUDY ASSUMPTIONS  64

2.7           RESEARCH LIMITATIONS             64

2.7.1        METHODOLOGY-RELATED LIMITATIONS           64

2.7.2        SCOPE-RELATED LIMITATIONS                 65

2.8           RISK ASSESSMENT           65

3               EXECUTIVE SUMMARY  66

4               PREMIUM INSIGHTS       72

4.1           TELEHEALTH & TELEMEDICINE MARKET OVERVIEW                 72

4.2           NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION     73

4.3           TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT            74

4.4           TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS              75

5               MARKET OVERVIEW       76

5.1           INTRODUCTION              76

5.2           MARKET DYNAMICS       76

5.2.1        DRIVERS               78

5.2.1.1    Growing geriatric population and increasing need for advanced healthcare infrastructure     78

5.2.1.2    Rising prevalence of chronic diseases                80

5.2.1.3    Reduced time and lower out-of-pocket costs   81

5.2.1.4    Advancements in telecommunication technologies        81

5.2.1.5    Shortage of skilled healthcare professionals     81

5.2.1.6    Increased government support and favorable regulatory policies                 82

5.2.1.7    Expansion of remote patient monitoring systems           83

5.2.2        RESTRAINTS      84

5.2.2.1    High investment costs for B2B models and lack of IT expertise                 84

5.2.2.2    State-to-state and inter-country regulatory variations   85

5.2.2.3    Behavioral reluctance to adopt new technologies            86

5.2.2.4    Rise in fraud and abuse in healthcare systems 86

5.2.2.5    Adherence to patient privacy, confidentiality, medical ethics                 87

5.2.3        OPPORTUNITIES              87

5.2.3.1    Growing use of wearables, applications, and sensors for virtual care         87

5.2.3.2    Emergence of AI and ML    88

5.2.3.3    Increasing shift toward outpatient care models               88

5.2.3.4    High utility of telemedicine against infectious communicable diseases and epidemics        89

5.2.3.5    Expansion of hospital-at-home (HaH) initiatives            90

5.2.3.6    Demand for electronic medical record-based telehealth services                 90

5.2.3.7    Rising incidence of mental illnesses and growing focus on

emotional well-being            90

5.2.4        CHALLENGES    91

5.2.4.1    Data security and confidentiality concerns      91

5.2.4.2    Limited data accessibility    95

5.2.4.3    Inability to maintain patient hygiene and cleanliness standards                 95

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            95

5.4           INDUSTRY TRENDS         96

5.5           ECOSYSTEM ANALYSIS  100

5.6           VALUE CHAIN ANALYSIS               103

5.7           TECHNOLOGY ANALYSIS             105

5.7.1        KEY TECHNOLOGIES     105

5.7.1.1    Video conferencing and real-time communication platforms                 105

5.7.1.2    AI and ML              105

5.7.1.3    Virtual assistants and chatbots           105

5.7.1.4    Voice recognition and natural language processing        106

5.7.1.5    EHR integration   106

5.7.1.6    Remote patient monitoring systems  106

5.7.2        COMPLEMENTARY TECHNOLOGIES       106

5.7.2.1    Edge computing   106

5.7.2.2    Cloud computing  107

5.7.2.3    Mobile health (mHealth) applications              107

5.7.2.4    Wearable devices, sensors, and IoT   107

5.7.3        ADJACENT TECHNOLOGIES       108

5.7.3.1    Digital therapeutics              108

5.7.3.2    Blockchain technology         108

5.7.3.3    Augmented reality and virtual reality                108

5.8           TARIFF AND REGULATORY ANALYSIS    109

5.8.1        TARIFF DATA ANALYSIS                109

5.8.1.1    Tariff data for HS code 9018               109

5.8.1.2    Tariff data for HS code 9021               110

5.8.1.3    Tariff data for HS code 9022               111

5.8.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             112

5.8.3        REGULATORY STANDARDS         114

5.8.4        REGULATORY FRAMEWORK       114

5.9           TRADE ANALYSIS             117

5.9.1        TRADE DATA FOR HSN CODE 90189099  117

5.9.1.1    Top 10 importers for HSN code 90189099       117

5.9.1.2    Top 10 exporters for HSN code 90189099       118

5.9.2        TRADE DATA FOR HSN CODE 9021           118

5.9.2.1    Top 10 importers for HSN code 9021               118

5.9.2.2    Top 10 exporters for HSN code 9021                119

5.9.3        TRADE DATA FOR HSN CODE 9022           119

5.9.3.1    Top 10 importers for HSN code 9022               119

5.9.3.2    Top 10 exporters for HSN code 9022                120

5.10         PRICING ANALYSIS          120

5.10.1      INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,

BY COMPONENT, 2023   121

5.10.2      INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES,

BY REGION, 2023               122

5.10.3      PRICING MODELS            123

5.11         PORTER’S FIVE FORCES ANALYSIS           123

5.11.1      THREAT OF NEW ENTRANTS      125

5.11.2      THREAT OF SUBSTITUTES          125

5.11.3      BARGAINING POWER OF BUYERS             125

5.11.4      BARGAINING POWER OF SUPPLIERS       125

5.11.5      INTENSITY OF COMPETITIVE RIVALRY 126

5.12         KEY STAKEHOLDERS & BUYING CRITERIA            126

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           126

5.12.2      KEY BUYING CRITERIA  127

5.13         PATENT ANALYSIS          128

5.13.1      PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE 128

5.13.2      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            129

5.14         UNMET NEEDS & END-USER EXPECTATIONS     130

5.14.1      UNMET NEEDS 130

5.14.2      END-USER EXPECTATIONS         131

5.15         KEY CONFERENCES & EVENTS, 2025–2026              132

5.16         CASE STUDY ANALYSIS 134

5.16.1      TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS  134

5.16.2      USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES         134

5.16.3      CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY’S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS        135

5.17         INVESTMENT & FUNDING SCENARIO     136

5.18         BUSINESS MODEL ANALYSIS      136

5.18.1      DIRECT-TO-PATIENT (D2P) MODEL       136

5.18.2      BUSINESS-TO-BUSINESS (B2B) MODEL  136

5.18.3      EMPLOYER-SPONSORED MODEL              137

5.18.4      SUBSCRIPTION-BASED MODEL 137

5.18.5      HYBRID TELEMEDICINE MODEL               137

5.18.6      PLATFORM-AS-A-SERVICE (PAAS) MODEL           137

5.18.7      VALUE-BASED CARE MODEL      138

5.19         IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET              138

5.19.1      KEY USE CASES 139

5.19.2      MAJOR CASE STUDIES   140

5.19.2.1  AI to redefine treatment effectiveness and safety            140

5.19.2.2  AI-driven chatbots and telehealth to enhance mental health and chronic disease management              141

5.19.3      IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              142

5.19.3.1  Healthcare IT and EHR systems        142

5.19.3.2  Pharmaceuticals & drug discovery     142

5.19.3.3  Mental health tech                143

5.19.3.4  Healthcare analytics and insights       143

5.19.4      USER READINESS & IMPACT ASSESSMENT            143

5.19.4.1  User readiness       143

5.19.4.1.1                User A: Hospitals 143

5.19.4.1.2                User B: Ambulatory surgery centers 143

5.19.4.2  Impact assessment                143

5.19.4.2.1                User A: Hospitals 144

5.19.4.2.2                User B: Ambulatory surgery centers 144

5.20         REIMBURSEMENT SCENARIO ANALYSIS                 144

6               TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT    147

6.1           INTRODUCTION              148

6.2           HARDWARE        148

6.2.1        TELEHEALTH KITS, CARTS, AND STATIONS        149

6.2.1.1    Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption                 149

6.2.2        PATIENT MONITORING DEVICES             150

6.2.2.1    Cardiac monitoring devices                 152

6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes  152

6.2.2.2    Neurological monitoring devices       153

6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth                153

6.2.2.3    Respiratory monitoring devices          154

6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment     154

6.2.2.4    Blood glucose monitoring devices     155

6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring            155

6.2.2.5    Fetal & neonatal monitoring devices 156

6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment             156

6.2.2.6    Weight monitoring devices 157

6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market 157

6.2.2.7    Multiparameter monitoring devices  158

6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth               158

6.2.2.8    Pulse oximeter devices         158

6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery      158

6.2.2.9    Other patient monitoring devices      159

6.3           SOFTWARE         160

6.3.1        TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY   160

6.3.1.1    EHR-centric software           161

6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms            161

6.3.1.2    Non-EHR-centric software 162

6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints              162

6.3.2        TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE                 162

6.3.2.1    Integrated software               163

6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data   163

6.3.2.2    Standalone software             164

6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption                 164

6.3.3        TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE               164

6.3.3.1    Remote patient monitoring platforms               165

6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth                 165

6.3.3.2    Virtual care platforms          167

6.3.3.2.1 Real-time interaction platforms         167

6.3.3.2.1.1              Synchronous nature and better healthcare access to drive segment        167

6.3.3.2.2 Store & forward platforms  168

6.3.3.2.2.1              Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth          168

6.3.3.3    Video conferencing platforms             169

6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth                169

6.3.3.4    Virtual sitting & nursing platforms    170

6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth               170

6.3.4        TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT            171

6.3.4.1    On-premise deployment models        171

6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market         171

6.3.4.2    Cloud-based deployment models       172

6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment     172

6.4           SERVICES             173

6.4.1        COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET  173

7               TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION          175

7.1           INTRODUCTION              176

7.2           CLINICAL CARE MANAGEMENT                 176

7.2.1        FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING,

AND FOLLOW-UP STRATEGIES TO DRIVE MARKET          176

7.3           PREVENTIVE CARE MANAGEMENT          177

7.3.1        PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT  177

7.4           DIAGNOSTICS & TREATMENT   178

7.4.1        DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS   178

7.5           REMOTE PATIENT MONITORING/PATIENT MONITORING   179

7.5.1        REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES           179

7.6           REHABILITATION & RECOVERY 180

7.6.1        ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES    180

7.7           ADMINISTRATIVE            181

7.7.1        EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY                 181

7.8           ANALYTICS & REPORTING           182

7.8.1        ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION 182

7.9           PATIENT ENGAGEMENT               183

7.9.1        PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO

TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS                 183

7.10         OTHER FUNCTIONS       184

8               TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION   186

8.1           INTRODUCTION              187

8.2           PRIMARY CARE 187

8.2.1        TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH             187

8.3           SPECIALTY CARE              188

8.3.1        TELERADIOLOGY            190

8.3.1.1    Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth            190

8.3.2        TELECARDIOLOGY         191

8.3.2.1    Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth               191

8.3.3        TELENEUROLOGY           192

8.3.3.1    High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth              192

8.3.4        DIABETES           193

8.3.4.1    Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth                193

8.3.5        RESPIRATORY DISORDERS          193

8.3.5.1    Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth        193

8.3.6        HYPERTENSION                194

8.3.6.1    Need for continuous monitoring and rise of remote care technologies to propel market growth               194

8.3.7        TELEDERMATOLOGY    195

8.3.7.1    High prevalence of skin cancer and dermatology-related diseases to augment segment growth                195

8.3.8        TELESTROKE     196

8.3.8.1    Rising incidence of stroke and increasing geriatric population to drive market          196

8.3.9        TELEPSYCHIATRY            197

8.3.9.1    Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth      197

8.3.10      OTHER SPECIALTY CARE APPLICATIONS              198

8.4           TELEICU              199

8.4.1        INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH             199

8.5           VIRTUAL SITTING & NURSING   200

8.5.1        INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH     200

8.6           OTHER APPLICATIONS 201

9               TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP 202

9.1           INTRODUCTION              203

9.2           PEDIATRICS       203

9.2.1        INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET         203

9.3           ADULTS                204

9.3.1        HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH             204

9.4           GERIATRICS       205

9.4.1        RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS           205

10            TELEHEALTH & TELEMEDICINE MARKET, BY END USER                 207

10.1         INTRODUCTION              208

10.2         HEALTHCARE PROVIDERS           208

10.2.1      HOSPITALS         210

10.2.1.1  Increasing demand for advanced and high-quality to drive market                 210

10.2.2      AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS  211

10.2.2.1  High preference, minimized patient downtime, and reduced hospital stay to augment segment growth         211

10.2.3      LONG-TERM CARE & ASSISTED LIVING FACILITIES                 212

10.2.3.1  Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment                 212

10.2.4      HOME HEALTHCARE      213

10.2.4.1  Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth           213

10.2.5      OTHER HEALTHCARE PROVIDERS           214

10.3         HEALTHCARE PAYERS   214

10.3.1      PUBLIC HEALTHCARE PAYERS  216

10.3.1.1  Increasing healthcare R&D investments and favorable policies to drive segment        216

10.3.2      PRIVATE HEALTHCARE PAYERS                217

10.3.2.1  Implementation of telehealth services for mental health issues and substance usage to drive segment               217

10.4         PATIENTS            217

10.4.1      RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS                 217

10.5         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 218

10.5.1      RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS               218

10.6         MEDTECH COMPANIES 219

10.6.1      INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH          219

10.7         OTHER END USERS         220

11            TELEHEALTH & TELEMEDICINE MARKET, BY REGION                 222

11.1         INTRODUCTION              223

11.2         NORTH AMERICA             223

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 223

11.2.2      US           231

11.2.2.1  US to dominate North American telehealth & telemedicine market during study period 231

11.2.3      CANADA               238

11.2.3.1  Push for digital health integration to drive higher adoption of telehealth services                 238

11.3         EUROPE               244

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      251

11.3.2      GERMANY           252

11.3.2.1  Favorable government legislation for digitalized healthcare to spur market growth              252

11.3.3      UK          258

11.3.3.1  Increased government focus on digital health solutions to aid market growth       258

11.3.4      FRANCE                265

11.3.4.1  Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment                265

11.3.5      ITALY    272

11.3.5.1  Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions     272

11.3.6      SPAIN    279

11.3.6.1  Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth         279

11.3.7      REST OF EUROPE             285

11.4         ASIA PACIFIC     292

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 300

11.4.2      CHINA  300

11.4.2.1  Investments in digital healthcare solutions to drive market                 300

11.4.3      JAPAN   307

11.4.3.1  Favorable legal revisions and advancements in video and audio communication to aid market growth                307

11.4.4      INDIA    314

11.4.4.1  Ongoing digital transformation initiatives through favorable government schemes to support market adoption           314

11.4.5      AUSTRALIA         321

11.4.5.1  Significant government investments in rural, remote, and specialist aged care services to fuel uptake       321

11.4.6      REST OF ASIA PACIFIC   328

11.5         LATIN AMERICA                334

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 335

11.5.2      BRAZIL 342

11.5.2.1  Increased availability of smartphones and improved internet connectivity to propel market growth                342

11.5.3      MEXICO                349

11.5.3.1  Regulatory improvements in telemedicine consultations to boost market growth       349

11.5.4      REST OF LATIN AMERICA             356

11.6         MIDDLE EAST & AFRICA                363

11.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 363

11.6.2      GCC COUNTRIES              370

11.6.2.1  Shortage of healthcare workforce to drive adoption of telehealth services  370

11.6.3      REST OF MIDDLE EAST & AFRICA             377

12            COMPETITIVE LANDSCAPE         384

12.1         INTRODUCTION              384

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            384

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN

TELEHEALTH & TELEMEDICINE MARKET             385

12.3         REVENUE ANALYSIS, 2019–2023  387

12.4         MARKET SHARE ANALYSIS, 2023                 389

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 392

12.5.1      STARS   392

12.5.2      EMERGING LEADERS     392

12.5.3      PERVASIVE PLAYERS      392

12.5.4      PARTICIPANTS 392

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         394

12.5.5.1  Company footprint               394

12.5.5.2  Region footprint   395

12.5.5.3  Function footprint                396

12.5.5.4  Application footprint            397

12.5.5.5  Component footprint           398

12.5.5.6  End-user footprint                399

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        400

12.6.1      PROGRESSIVE COMPANIES         400

12.6.2      RESPONSIVE COMPANIES            400

12.6.3      DYNAMIC COMPANIES  400

12.6.4      STARTING BLOCKS         400

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 402

12.6.5.1  Detailed list of key startups/SMEs    402

12.6.5.2  Competitive benchmarking of key startups/SMEs          402

12.7         COMPANY VALUATION & FINANCIAL METRICS 403

12.8         BRAND/SOFTWARE COMPARATIVE ANALYSIS   404

12.9         COMPETITIVE SCENARIO             405

12.9.1      PRODUCT LAUNCHES & APPROVALS     405

12.9.2      DEALS  406

12.9.3      EXPANSIONS     407

12.9.4      OTHER DEVELOPMENTS              407

13            COMPANY PROFILES      409

13.1         KEY PLAYERS     409

13.1.1      MEDTRONIC      409

13.1.1.1  Business overview 409

13.1.1.2  Products/Services/Solutions offered 410

13.1.1.3  Recent developments           412

13.1.1.3.1                Product launches & approvals            412

13.1.1.3.2                Deals      413

13.1.1.4  MnM view              414

13.1.1.4.1                Right to win           414

13.1.1.4.2                Strategic choices   414

13.1.1.4.3                Weaknesses & competitive threats     414

13.1.2      TELADOC HEALTH, INC.               415

13.1.2.1  Business overview 415

13.1.2.2  Products/Services/Solutions offered 416

13.1.2.3  Recent developments           417

13.1.2.3.1                Product launches & enhancements    417

13.1.2.3.2                Deals      418

13.1.2.4  MnM view              419

13.1.2.4.1                Right to win           419

13.1.2.4.2                Strategic choices   419

13.1.2.4.3                Weaknesses & competitive threats     419

13.1.3      CISCO SYSTEMS, INC.     420

13.1.3.1  Business overview 420

13.1.3.2  Products/Services/Solutions offered 421

13.1.3.3  MnM view              423

13.1.3.3.1                Right to win           423

13.1.3.3.2                Strategic choices   423

13.1.3.3.3                Weaknesses & competitive threats     423

13.1.4      KONINKLIJKE PHILIPS N.V.          424

13.1.4.1  Business overview 424

13.1.4.2  Products/Services/Solutions offered 425

13.1.4.3  Recent developments           428

13.1.4.3.1                Product launches & approvals            428

13.1.4.3.2                Deals      429

13.1.4.4  MnM view              431

13.1.4.4.1                Right to win           431

13.1.4.4.2                Strategic choices   431

13.1.4.4.3                Weaknesses & competitive threats     431

13.1.5      ZOOM COMMUNICATIONS, INC.               432

13.1.5.1  Business overview 432

13.1.5.2  Products/Services/Solutions offered 433

13.1.5.3  Recent developments           433

13.1.5.3.1                Deals      433

13.1.5.4  MnM view              434

13.1.5.4.1                Right to win           434

13.1.5.4.2                Strategic choices   434

13.1.5.4.3                Weaknesses & competitive threats     434

13.1.6      GE HEALTHCARE             435

13.1.6.1  Business overview 435

13.1.6.2  Products/Services/Solutions offered 436

13.1.6.3  Recent developments           438

13.1.6.3.1                Product launches & approvals            438

13.1.6.3.2                Deals      438

13.1.7      EPIC SYSTEMS CORPORATION  440

13.1.7.1  Business overview 440

13.1.7.2  Products/Services/Solutions offered 440

13.1.7.3  Recent developments           442

13.1.7.3.1                Product launches & enhancements    442

13.1.7.3.2                Deals      443

13.1.8      ORACLE                444

13.1.8.1  Business overview 444

13.1.8.2  Products/Services/Solutions offered 445

13.1.8.3  Recent developments           447

13.1.8.3.1                Product launches  447

13.1.8.3.2                Deals      447

13.1.9      DOXIMITY, INC.                450

13.1.9.1  Business overview 450

13.1.9.2  Products/Services/Solutions offered 451

13.1.9.3  Recent developments           452

13.1.9.3.1                Product enhancements        452

13.1.9.3.2                Deals      452

13.1.9.3.3                Other developments             453

13.1.10   AMERICAN WELL              454

13.1.10.1                 Business overview 454

13.1.10.2                 Products/Services/Solutions offered 455

13.1.10.3                 Recent developments           456

13.1.10.3.1             Product launches  456

13.1.10.3.2             Deals      457

13.1.10.3.3             Other developments             457

13.1.11   SIEMENS HEALTHINEERS AG      458

13.1.11.1                 Business overview 458

13.1.11.2                 Products/Services/Solutions offered 459

13.1.11.3                 Recent developments           461

13.1.11.3.1             Product launches & approvals            461

13.1.11.3.2             Deals      461

13.1.12   INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)                 463

13.1.12.1                 Business overview 463

13.1.12.2                 Products/Services/Solutions offered 463

13.1.12.3                 Recent developments           464

13.1.12.3.1             Deals      464

13.1.12.3.2             Other developments             465

13.1.13   AMC HEALTH    466

13.1.13.1                 Business overview 466

13.1.13.2                 Products/Services/Solutions offered 466

13.1.13.3                 Recent developments           467

13.1.13.3.1             Deals      467

13.1.14   TELESPECIALISTS            468

13.1.14.1                 Business overview 468

13.1.14.2                 Products/Services/Solutions offered 468

13.1.14.3                 Recent developments           469

13.1.14.3.1             Product launches  469

13.1.14.3.2             Deals      469

13.1.14.3.3             Other developments             469

13.1.15   WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)                 470

13.1.15.1                 Business overview 470

13.1.15.2                 Products/Services/Solutions offered 471

13.1.15.3                 Recent developments           471

13.1.15.3.1             Product launches  471

13.1.15.3.2             Deals      472

13.1.15.3.3             Expansions             472

13.1.16   CAREGILITY       473

13.1.16.1                 Business overview 473

13.1.16.2                 Products/Services/Solutions offered 473

13.1.16.3                 Recent developments           474

13.1.16.3.1             Product launches  474

13.1.16.3.2             Deals      474

13.1.16.3.3             Other developments             475

13.1.17   CVS HEALTH      476

13.1.17.1                 Business overview 476

13.1.17.2                 Products/Services/Solutions offered 477

13.1.17.3                 Recent developments           478

13.1.17.3.1             Product launches  478

13.1.17.3.2             Deals      478

13.1.18   EVERNORTH HEALTH, INC.         479

13.1.18.1                 Business overview 479

13.1.18.2                 Products/Services/Solutions offered 481

13.1.18.3                 Recent developments           482

13.1.18.3.1             Deals      482

13.1.19   ELATION              483

13.1.19.1                 Business overview 483

13.1.19.2                 Products/Services/Solutions offered 483

13.1.19.3                 Recent developments           483

13.1.19.3.1             Deals      483

13.1.20   IRON BOW TECHNOLOGIES        484

13.1.20.1                 Business overview 484

13.1.20.2                 Products/Services/Solutions offered 484

13.2         OTHER PLAYERS              486

13.2.1      TIMEDOC, INC. 486

13.2.2      CEREBRAL INC. 487

13.2.3      KINDBODY         488

13.2.4      TRANSCARENT 489

13.2.5      CARESIMPLE INC.            490

14            APPENDIX           491

14.1         DISCUSSION GUIDE        491

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                497

14.3         CUSTOMIZATION OPTIONS        499

14.4         RELATED REPORTS         499

14.5         AUTHOR DETAILS           500

LIST OF TABLES

TABLE 1                TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS       45

TABLE 2                TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS  64

TABLE 3                TELEHEALTH & TELEMEDICINE MARKET: RISK ASSESSMENT     65

TABLE 4                MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 77

TABLE 5                CHRONIC DISEASES AND RELATED COST BURDEN IN US  80

TABLE 6                RECENT DEVELOPMENTS IN REMOTE PATIENT MONITORING SYSTEMS,

JANUARY 2023–JANUARY 2025     83

TABLE 7                US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH           85

TABLE 8                TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024            93

TABLE 9                INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET              96

TABLE 10              OVERVIEW OF TELEHEALTH USE CASES                 99

TABLE 11              TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 102

TABLE 12              AVERAGE TARIFF FOR HS CODE 9018, 2023                 109

TABLE 13              AVERAGE TARIFF FOR HS CODE 9021, 2023                 110

TABLE 14              AVERAGE TARIFF FOR HS CODE 9022, 2023                 111

TABLE 15              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  112

TABLE 16              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  112

TABLE 17              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  113

TABLE 18              TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS         114

TABLE 19              REGULATORY REQUIREMENTS IN NORTH AMERICA             114

TABLE 20              REGULATORY REQUIREMENTS IN EUROPE                 115

TABLE 21              REGULATORY REQUIREMENTS IN ASIA PACIFIC                 115

TABLE 22              REGULATORY REQUIREMENTS IN LATIN AMERICA             116

TABLE 23              REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 116

TABLE 24              TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY,

2019–2023 (USD THOUSAND)      117

TABLE 25              TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY,

2019–2023 (USD THOUSAND)      118

TABLE 26              TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY,

2019–2023 (USD THOUSAND)      118

TABLE 27              TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY,

2019–2023 (USD THOUSAND)      119

TABLE 28              TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY,

2019–2023 (USD THOUSAND)      119

TABLE 29              TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY,

2019–2023 (USD THOUSAND)      120

TABLE 30              COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD) 121

TABLE 31              INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,

BY COMPONENT, 2023   122

TABLE 32              AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS, 2023 122

TABLE 33              INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES,

BY REGION, 2023               123

TABLE 34              TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 124

TABLE 35              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE         126

TABLE 36              KEY BUYING CRITERIA FOR TOP THREE COMPONENTS  127

TABLE 37              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR

TELEHEALTH & TELEHEALTH   129

TABLE 38              UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET              131

TABLE 39              END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET              131

TABLE 40              TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF

KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026                 132

TABLE 41              CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY

WITH TEBRA’S INTEGRATED SOLUTIONS            134

TABLE 42              CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY

ROOM TRANSFERS FROM SKILLED NURSING FACILITIES                 134

TABLE 43              CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY’S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS      135

TABLE 44              AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY      140

TABLE 45              AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL

HEALTH AND CHRONIC DISEASE MANAGEMENT             141

TABLE 46              TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND

REIMBURSEMENT ANALYSIS      145

TABLE 47              TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            148

TABLE 48              TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION,

2022–2030 (USD MILLION)            149

TABLE 49              TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            149

TABLE 50              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR TELEHEALTH KITS, CARTS, AND STATIONS, BY REGION, 2022–2030 (USD MILLION)          150

TABLE 51              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)            150

TABLE 52              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)       151

TABLE 53              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (THOUSANDS UNITS)          151

TABLE 54              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)            152

TABLE 55              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          153

TABLE 56              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          155

TABLE 57              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          156

TABLE 58              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          156

TABLE 59              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)            157

TABLE 60              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          158

TABLE 61              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PULSE OXIMETER DEVICES, BY REGION, 2022–2030 (USD MILLION) 159

TABLE 62              TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR OTHER PATIENT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION)          159

TABLE 63              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION,

2022–2030 (USD MILLION)            160

TABLE 64              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            161

TABLE 65              TELEHEALTH & TELEMEDICINE EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)                 161

TABLE 66              TELEHEALTH & TELEMEDICINE NON-EHR-CENTRIC SOFTWARE MARKET,

BY REGION, 2022–2030 (USD MILLION)   162

TABLE 67              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)                 163

TABLE 68              TELEHEALTH & TELEMEDICINE INTEGRATED SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)                 163

TABLE 69              TELEHEALTH & TELEMEDICINE STANDALONE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)                 164

TABLE 70              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            165

TABLE 71              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR REMOTE PATIENT MONITORING PLATFORMS, BY REGION, 2022–2030 (USD MILLION)          166

TABLE 72              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL CARE PLATFORMS, BY REGION, 2022–2030 (USD MILLION)       167

TABLE 73              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIDEO CONFERENCING PLATFORMS, BY REGION, 2022–2030 (USD MILLION)            169

TABLE 74              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL SITTING & NURSING PLATFORMS, BY REGION, 2022–2030 (USD MILLION)          170

TABLE 75              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT,

2022–2030 (USD MILLION)            171

TABLE 76              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT MODELS, BY REGION, 2022–2030 (USD MILLION)            172

TABLE 77              TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY REGION, 2022–2030 (USD MILLION)          173

TABLE 78              TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            174

TABLE 79              TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            176

TABLE 80              TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT,

BY REGION, 2022–2030 (USD MILLION)   177

TABLE 81              TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT,

BY REGION, 2022–2030 (USD MILLION)   178

TABLE 82              TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT,

BY REGION, 2022–2030 (USD MILLION)   179

TABLE 83              TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/ PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION)          180

TABLE 84              TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY,

BY REGION, 2022–2030 (USD MILLION)   181

TABLE 85              TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE, BY REGION,

2022–2030 (USD MILLION)            182

TABLE 86              TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING,

BY REGION, 2022–2030 (USD MILLION)   183

TABLE 87              TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022–2030 (USD MILLION)                 184

TABLE 88              TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)                 185

TABLE 89              TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            187

TABLE 90              TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE, BY REGION,

2022–2030 (USD MILLION)            188

TABLE 91              TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE,

2022–2030 (USD MILLION)            189

TABLE 92              TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY REGION,

2022–2030 (USD MILLION)            189

TABLE 93              TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION,

2022–2030 (USD MILLION)            190

TABLE 94              TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022–2030 (USD MILLION)                 191

TABLE 95              TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY, BY REGION, 2022–2030 (USD MILLION)                 192

TABLE 96              TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES, BY REGION,

2022–2030 (USD MILLION)            193

TABLE 97              TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS,

BY REGION, 2022–2030 (USD MILLION)   194

TABLE 98              TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION, BY REGION,

2022–2030 (USD MILLION)            195

TABLE 99              TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022–2030 (USD MILLION)                 196

TABLE 100            TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION,

2022–2030 (USD MILLION)            197

TABLE 101            TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION,

2022–2030 (USD MILLION)            198

TABLE 102            TELEHEALTH & TELEMEDICINE MARKET FOR OTHER SPECIALTY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 199

TABLE 103            TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION,

2022–2030 (USD MILLION)            200

TABLE 104            TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING,

BY REGION, 2022–2030 (USD MILLION)   201

TABLE 105            TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)                 201

TABLE 106            TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            203

TABLE 107            TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS, BY REGION,

2022–2030 (USD MILLION)            204

TABLE 108            TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS, BY REGION,

2022–2030 (USD MILLION)            205

TABLE 109            TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS, BY REGION,

2022–2030 (USD MILLION)            206

TABLE 110            TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            208

TABLE 111            TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 209

TABLE 112            TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY REGION, 2022–2030 (USD MILLION)   210

TABLE 113            TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS, BY REGION,

2022–2030 (USD MILLION)            211

TABLE 114            TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)            212

TABLE 115            TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)            213

TABLE 116            TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD MILLION)                 213

TABLE 117            TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS,

BY REGION, 2022–2030 (USD MILLION)   214

TABLE 118            TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 215

TABLE 119            TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)                 215

TABLE 120            TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC HEALTHCARE PAYERS,

BY REGION, 2022–2030 (USD MILLION)   216

TABLE 121            TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE HEALTHCARE PAYERS,

BY REGION, 2022–2030 (USD MILLION)   217

TABLE 122            TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION,

2022–2030 (USD MILLION)            218

TABLE 123            TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)          219

TABLE 124            TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)                 220

TABLE 125            TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)                 221

TABLE 126            TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)          223

TABLE 127            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            224

TABLE 128            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            225

TABLE 129            NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            225

TABLE 130            NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                 226

TABLE 131            NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             226

TABLE 132            NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          227

TABLE 133            NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            227

TABLE 134            NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      227

TABLE 135            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            228

TABLE 136            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            228

TABLE 137            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)       229

TABLE 138            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            229

TABLE 139            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            230

TABLE 140            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                230

TABLE 141            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            231

TABLE 142            US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            232

TABLE 143            US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            232

TABLE 144            US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)       233

TABLE 145            US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            233

TABLE 146            US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)                 234

TABLE 147            US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            234

TABLE 148            US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT,

2022–2030 (USD MILLION)            234

TABLE 149            US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            235

TABLE 150            US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            235

TABLE 151            US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)                 236

TABLE 152            US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            236

TABLE 153            US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            237

TABLE 154            US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         237

TABLE 155            US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 238

TABLE 156            CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            238

TABLE 157            CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            239

TABLE 158            CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            239

TABLE 159            CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 240

TABLE 160            CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          240

TABLE 161            CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            240

TABLE 162            CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            241

TABLE 163            CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            241

TABLE 164            CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            242

TABLE 165            CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            242

TABLE 166            CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            243

TABLE 167            CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            243

TABLE 168            CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 244

TABLE 169            CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         244

TABLE 170            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            245

TABLE 171            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            245

TABLE 172            EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            246

TABLE 173            EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            246

TABLE 174            EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 247

TABLE 175            EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          247

TABLE 176            EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            247

TABLE 177            EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            248

TABLE 178            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            248

TABLE 179            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            249

TABLE 180            EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            249

TABLE 181            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            250

TABLE 182            EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            250

TABLE 183            EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 251

TABLE 184            EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         251

TABLE 185            GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            252

TABLE 186            GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            253

TABLE 187            GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            253

TABLE 188            GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 254

TABLE 189            GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          254

TABLE 190            GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            254

TABLE 191            GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            255

TABLE 192            GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            255

TABLE 193            GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            256

TABLE 194            GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,

BY TYPE, 2022–2030 (USD MILLION)         256

TABLE 195            GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            257

TABLE 196            GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            257

TABLE 197            GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 258

TABLE 198            GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         258

TABLE 199            UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            259

TABLE 200            UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            259

TABLE 201            UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                260

TABLE 202            UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            260

TABLE 203            UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)                 261

TABLE 204            UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            261

TABLE 205            UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT,

2022–2030 (USD MILLION)            261

TABLE 206            UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            262

TABLE 207            UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            262

TABLE 208            UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)                 263

TABLE 209            UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            263

TABLE 210            UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            264

TABLE 211            UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         264

TABLE 212            UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 265

TABLE 213            FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            266

TABLE 214            FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            266

TABLE 215            FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            267

TABLE 216            FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 267

TABLE 217            FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          268

TABLE 218            FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            268

TABLE 219            FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      268

TABLE 220            FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            269

TABLE 221            FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            269

TABLE 222            FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            270

TABLE 223            FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            270

TABLE 224            FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            271

TABLE 225            FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 271

TABLE 226            FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         272

TABLE 227            ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            273

TABLE 228            ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            273

TABLE 229            ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                274

TABLE 230            ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            274

TABLE 231            ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            275

TABLE 232            ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            275

TABLE 233            ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            275

TABLE 234            ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            276

TABLE 235            ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            276

TABLE 236            ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            277

TABLE 237            ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            277

TABLE 238            ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            278

TABLE 239            ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         278

TABLE 240            ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         279

TABLE 241            SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            279

TABLE 242            SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            280

TABLE 243            SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            280

TABLE 244            SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            281

TABLE 245            SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          281

TABLE 246            SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            281

TABLE 247            SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      282

TABLE 248            SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            282

TABLE 249            SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            283

TABLE 250            SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            283

TABLE 251            SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            284

TABLE 252            SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            284

TABLE 253            SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         285

TABLE 254            SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         285

TABLE 255            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            286

TABLE 256            REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         286

TABLE 257            REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET

FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            287

TABLE 258            REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             287

TABLE 259            REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          288

TABLE 260            REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         288

TABLE 261            REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      288

TABLE 262            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            289

TABLE 263            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            289

TABLE 264            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)       290

TABLE 265            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            290

TABLE 266            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            291

TABLE 267            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                291

TABLE 268            REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            292

TABLE 269            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            294

TABLE 270            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            294

TABLE 271            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)                 294

TABLE 272            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                295

TABLE 273            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 295

TABLE 274            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          296

TABLE 275            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)                 296

TABLE 276            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      296

TABLE 277            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            297

TABLE 278            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            297

TABLE 279            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,

BY TYPE, 2022–2030 (USD MILLION)         298

TABLE 280            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            298

TABLE 281            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            299

TABLE 282            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 299

TABLE 283            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            300

TABLE 284            CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            301

TABLE 285            CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            301

TABLE 286            CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                302

TABLE 287            CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 302

TABLE 288            CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            303

TABLE 289            CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            303

TABLE 290            CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            303

TABLE 291            CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            304

TABLE 292            CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            304

TABLE 293            CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            305

TABLE 294            CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            305

TABLE 295            CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            306

TABLE 296            CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         306

TABLE 297            CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         307

TABLE 298            JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            308

TABLE 299            JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            308

TABLE 300            JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            309

TABLE 301            JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            309

TABLE 302            JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            310

TABLE 303            JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            310

TABLE 304            JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            310

TABLE 305            JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            311

TABLE 306            JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            311

TABLE 307            JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            312

TABLE 308            JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            312

TABLE 309            JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            313

TABLE 310            JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         313

TABLE 311            JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         314

TABLE 312            INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            315

TABLE 313            INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            315

TABLE 314            INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                316

TABLE 315            INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            316

TABLE 316            INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            317

TABLE 317            INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            317

TABLE 318            INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            317

TABLE 319            INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            318

TABLE 320            INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            318

TABLE 321            INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            319

TABLE 322            INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            319

TABLE 323            INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            320

TABLE 324            INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         320

TABLE 325            INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         321

TABLE 326            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            322

TABLE 327            AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            322

TABLE 328            AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                323

TABLE 329            AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 323

TABLE 330            AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          324

TABLE 331            AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            324

TABLE 332            AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            324

TABLE 333            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            325

TABLE 334            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            325

TABLE 335            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,

BY TYPE, 2022–2030 (USD MILLION)         326

TABLE 336            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            326

TABLE 337            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            327

TABLE 338            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 327

TABLE 339            AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         328

TABLE 340            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            328

TABLE 341            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         329

TABLE 342            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET

FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            329

TABLE 343            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             330

TABLE 344            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          330

TABLE 345            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         330

TABLE 346            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      331

TABLE 347            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            331

TABLE 348            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            332

TABLE 349            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)       332

TABLE 350            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION)            333

TABLE 351            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)            333

TABLE 352            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR

HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 334

TABLE 353            REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR

HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 334

TABLE 354            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            336

TABLE 355            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            336

TABLE 356            LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            336

TABLE 357            LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            337

TABLE 358            LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             337

TABLE 359            LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          338

TABLE 360            LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            338

TABLE 361            LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      338

TABLE 362            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            339

TABLE 363            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            339

TABLE 364            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,

BY TYPE, 2022–2030 (USD MILLION)         340

TABLE 365            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            340

TABLE 366            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            341

TABLE 367            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR

HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 341

TABLE 368            LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR

HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 342

TABLE 369            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            343

TABLE 370            BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            343

TABLE 371            BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR

PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            344

TABLE 372            BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,

2022–2030 (USD MILLION)            344

TABLE 373            BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          345

TABLE 374            BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            345

TABLE 375            BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            345

TABLE 376            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            346

TABLE 377            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            346

TABLE 378            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            347

TABLE 379            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            347

TABLE 380            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            348

TABLE 381            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         348

TABLE 382            BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         349

TABLE 383            MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            350

TABLE 384            MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            350

TABLE 385            MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                351

TABLE 386            MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)                 351

TABLE 387            MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            352

TABLE 388            MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            352

TABLE 389            MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)            352

TABLE 390            MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            353

TABLE 391            MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            353

TABLE 392            MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            354

TABLE 393            MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            354

TABLE 394            MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            355

TABLE 395            MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 355

TABLE 396            MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2022–2030 (USD MILLION)         356

TABLE 397            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            357

TABLE 398            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         357

TABLE 399            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET

FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            358

TABLE 400            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             358

TABLE 401            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          359

TABLE 402            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         359

TABLE 403            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      359

TABLE 404            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            360

TABLE 405            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,

BY APPLICATION, 2022–2030 (USD MILLION)       360

TABLE 406            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET

FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)                 361

TABLE 407            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,

BY AGE GROUP, 2022–2030 (USD MILLION)           361

TABLE 408            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,

BY END USER, 2022–2030 (USD MILLION)             362

TABLE 409            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                362

TABLE 410            REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            363

TABLE 411            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)                 364

TABLE 412            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            364

TABLE 413            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         364

TABLE 414            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET

FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            365

TABLE 415            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             365

TABLE 416            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          366

TABLE 417            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         366

TABLE 418            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      366

TABLE 419            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            367

TABLE 420            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            367

TABLE 421            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR

SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)    368

TABLE 422            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION)            368

TABLE 423            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)            369

TABLE 424            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                369

TABLE 425            MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            370

TABLE 426            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            370

TABLE 427            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            371

TABLE 428            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                 371

TABLE 429            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY MODALITY, 2022–2030 (USD MILLION)             372

TABLE 430            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY INTEGRATION TYPE, 2022–2030 (USD MILLION)          372

TABLE 431            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         372

TABLE 432            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2030 (USD MILLION)      373

TABLE 433            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            373

TABLE 434            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            374

TABLE 435            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)       374

TABLE 436            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2022–2030 (USD MILLION)            375

TABLE 437            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2022–2030 (USD MILLION)            375

TABLE 438            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                376

TABLE 439            GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            376

TABLE 440            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,

BY COMPONENT, 2022–2030 (USD MILLION)        377

TABLE 441            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 377

TABLE 442            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION)                 378

TABLE 443            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)       378

TABLE 444            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)            379

TABLE 445            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 379

TABLE 446            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)       379

TABLE 447            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             380

TABLE 448            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,

BY APPLICATION, 2022–2030 (USD MILLION)       380

TABLE 449            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION)            381

TABLE 450            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,

BY AGE GROUP, 2022–2030 (USD MILLION)           381

TABLE 451            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,

BY END USER, 2022–2030 (USD MILLION)               382

TABLE 452            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            382

TABLE 453            REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET

FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 383

TABLE 454            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021–JANUARY 2025         385

TABLE 455            TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION         390

TABLE 456            TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT     395

TABLE 457            TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT                396

TABLE 458            TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT         397

TABLE 459            TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT          398

TABLE 460            TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT            399

TABLE 461            TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES             402

TABLE 462            TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF

KEY EMERGING PLAYERS/STARTUPS     402

TABLE 463            TELEHEALTH & TELEMEDICINE MARKET:

PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025        405

TABLE 464            TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2021–JANUARY 2025      406

TABLE 465            TELEHEALTH & TELEMEDICINE MARKET:

EXPANSIONS, JANUARY 2021–JANUARY 2025         407

TABLE 466            TELEHEALTH & TELEMEDICINE MARKET:

OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025                 407

TABLE 467            MEDTRONIC: COMPANY OVERVIEW       409

TABLE 468            MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    410

TABLE 469            MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025           412

TABLE 470            MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025        413

TABLE 471            TELADOC HEALTH, INC.: COMPANY OVERVIEW                 415

TABLE 472            TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    416

TABLE 473            TELADOC HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     417

TABLE 474            TELADOC HEALTH, INC.: DEALS, JANUARY 2021–JANUARY 2025    418

TABLE 475            CISCO SYSTEMS, INC.: COMPANY OVERVIEW                 420

TABLE 476            CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    421

TABLE 477            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          424

TABLE 478            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    425

TABLE 479            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     428

TABLE 480            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025         429

TABLE 481            ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW          432

TABLE 482            ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    433

TABLE 483            ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2021–JANUARY 2025     433

TABLE 484            GE HEALTHCARE: COMPANY OVERVIEW                 435

TABLE 485            GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED    436

TABLE 486            GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     438

TABLE 487            GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025    438

TABLE 488            EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW          440

TABLE 489            EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    440

TABLE 490            EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     442

TABLE 491            EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025     443

TABLE 492            ORACLE: COMPANY OVERVIEW                444

TABLE 493            ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED             445

TABLE 494            ORACLE: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025    447

TABLE 495            ORACLE: DEALS, JANUARY 2021–JANUARY 2025                 447

TABLE 496            DOXIMITY, INC.: COMPANY OVERVIEW 450

TABLE 497            DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    451

TABLE 498            DOXIMITY, INC.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025     452

TABLE 499            DOXIMITY, INC.: DEALS, JANUARY 2021–JANUARY 2025    452

TABLE 500            DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     453

TABLE 501            AMERICAN WELL: COMPANY OVERVIEW                 454

TABLE 502            AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED    455

TABLE 503            AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025     456

TABLE 504            AMERICAN WELL: DEALS, JANUARY 2021–JANUARY 2025    457

TABLE 505            AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     457

TABLE 506            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          458

TABLE 507            SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED    459

TABLE 508            SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     461

TABLE 509            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–JANUARY 2025         461

TABLE 510            INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): COMPANY OVERVIEW 463

TABLE 511            INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED                 463

TABLE 512            INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.):

DEALS, JANUARY 2021–JANUARY 2025      464

TABLE 513            INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.):

OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025                 465

TABLE 514            AMC HEALTH: COMPANY OVERVIEW     466

TABLE 515            AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED    466

TABLE 516            AMC HEALTH: DEALS, JANUARY 2021–JANUARY 2025        467

TABLE 517            TELESPECIALISTS: COMPANY OVERVIEW                 468

TABLE 518            TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    468

TABLE 519            TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025     469

TABLE 520            TELESPECIALISTS: DEALS, JANUARY 2021–JANUARY 2025    469

TABLE 521            TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     469

TABLE 522            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW              470

TABLE 523            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED                 471

TABLE 524            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.):

PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025      471

TABLE 525            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.):

DEALS, JANUARY 2021- JANUARY 2025     472

TABLE 526            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.):

EXPANSIONS, JANUARY 2021–JANUARY 2025         472

TABLE 527            CAREGILITY: COMPANY OVERVIEW        473

TABLE 528            CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED    473

TABLE 529            CAREGILITY: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025         474

TABLE 530            CAREGILITY: DEALS, JANUARY 2021–JANUARY 2025        474

TABLE 531            CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     475

TABLE 532            CVS HEALTH: COMPANY OVERVIEW      476

TABLE 533            CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED    477

TABLE 534            CVS HEALTH: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025         478

TABLE 535            CVS HEALTH: DEALS, JANUARY 2021- JANUARY 2025        478

TABLE 536            EVERNORTH HEALTH, INC.: COMPANY OVERVIEW          479

TABLE 537            EVERNORTH HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    481

TABLE 538            EVERNORTH HEALTH, INC.: DEALS, JANUARY 2021–JANUARY 2025         482

TABLE 539            ELATION: COMPANY OVERVIEW              483

TABLE 540            ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED             483

TABLE 541            ELATION: DEALS, JANUARY 2021–JANUARY 2025                 483

TABLE 542            IRON BOW TECHNOLOGIES: COMPANY OVERVIEW          484

TABLE 543            IRON BOW TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED    484

TABLE 544            TIMEDOC, INC.: COMPANY OVERVIEW  486

TABLE 545            CEREBRAL INC.: COMPANY OVERVIEW 487

TABLE 546            KINDBODY: COMPANY OVERVIEW          488

TABLE 547            TRANSACARENT: COMPANY OVERVIEW                 489

TABLE 548            CARESIMPLE INC.: COMPANY OVERVIEW                 490

LIST OF FIGURES

FIGURE 1              TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION &

GEOGRAPHICAL SPREAD             44

FIGURE 2              TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED      47

FIGURE 3              TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN         50

FIGURE 4              TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES        52

FIGURE 5              TELEHEALTH & TELEMEDICINE MARKET: KEY SOURCES OF PRIMARY DATA     53

FIGURE 6              TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES               54

FIGURE 7              TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES       55

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION            55

FIGURE 9              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           56

FIGURE 10            MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            57

FIGURE 11            BOTTOM-UP APPROACH: END-USER SPENDING ON TELEHEALTH & TELEMEDICINE       59

FIGURE 12            TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH          60

FIGURE 13            TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)              61

FIGURE 14            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 62

FIGURE 15            TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION             63

FIGURE 16            TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,

2024 VS. 2030 (USD MILLION)      66

FIGURE 17            TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,

2024 VS. 2030 (USD MILLION)      67

FIGURE 18            TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,

2024 VS. 2030 (USD MILLION)      68

FIGURE 19            TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,

2024 VS. 2030 (USD MILLION)      69

FIGURE 20            TELEHEALTH & TELEMEDICINE MARKET, BY END USER,

2024 VS. 2030 (USD MILLION)      70

FIGURE 21            TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT  71

FIGURE 22            NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE

EXPENSES TO DRIVE MARKET   72

FIGURE 23            US AND HEALTHCARE PROVIDERS COMMANDED LARGEST MARKET

SHARE IN 2023   73

FIGURE 24            CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030                 74

FIGURE 25            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES

DURING FORECAST PERIOD       75

FIGURE 26            TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     76

FIGURE 27            INCREASE IN POPULATION, 2022 VS. 2030 VS. 2050 (MILLION) 79

FIGURE 28            US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, BY STATE (SEPTEMBER 2024)            89

FIGURE 29            HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024           92

FIGURE 30            US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024              92

FIGURE 31            INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023   93

FIGURE 32            TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS                 96

FIGURE 33            TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS  101

FIGURE 34            TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS               104

FIGURE 35            TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS           124

FIGURE 36            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS            126

FIGURE 37            KEY BUYING CRITERIA FOR TOP THREE COMPONENTS  127

FIGURE 38            GLOBAL PATENT PUBLICATION TRENDS IN

TELEHEALTH & TELEMEDICINE, 2015–2024          128

FIGURE 39            JURISDICTION AND TOP APPLICANT ANALYSIS IN

TELEHEALTH & TELEMEDICINE (2024)  129

FIGURE 40            TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015–DECEMBER 2024)             130

FIGURE 41            FUNDING AND NUMBER OF DEALS IN TELEHEALTH & TELEMEDICINE MARKET             136

FIGURE 42            POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET              139

FIGURE 43            NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT      224

FIGURE 44            ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT       293

FIGURE 45            REVENUE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, 2019–2023 (USD MILLION)            388

FIGURE 46            MARKET SHARE ANALYSIS OF KEY PLAYERS IN

TELEHEALTH & TELEMEDICINE MARKET (2023)                389

FIGURE 47            TELEHEALTH & TELEMEDICINE MARKET:

COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023  393

FIGURE 48            TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 394

FIGURE 49            TELEHEALTH & TELEMEDICINE MARKET:

COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 401

FIGURE 50            EV/EBITDA OF KEY VENDORS, 2024         403

FIGURE 51            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS, 2024 403

FIGURE 52            TELEHEALTH & TELEMEDICINE MARKET:

BRAND/SOFTWARE COMPARATIVE ANALYSIS   404

FIGURE 53            MEDTRONIC: COMPANY SNAPSHOT      410

FIGURE 54            TELADOC HEALTH, INC.: COMPANY SNAPSHOT                 416

FIGURE 55            CISCO SYSTEMS, INC.: COMPANY SNAPSHOT                 421

FIGURE 56            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT          425

FIGURE 57            ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT          432

FIGURE 58            GE HEALTHCARE: COMPANY SNAPSHOT                 436

FIGURE 59            ORACLE: COMPANY SNAPSHOT                445

FIGURE 60            DOXIMITY, INC.: COMPANY SNAPSHOT 451

FIGURE 61            AMERICAN WELL: COMPANY SNAPSHOT                 454

FIGURE 62            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT          459

FIGURE 63            WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT              470

FIGURE 64            CVS HEALTH: COMPANY SNAPSHOT      477

FIGURE 65            EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT          480

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 尿失禁デバイス市場 – 2030年までの世界予測 2025-03-12
• 医療用加湿器市場 – 2029年までの世界予測 2025-03-11
• BOPETフィルム市場 – 2029年までの世界予測 2025-03-11
• 金ナノ粒子市場 – 2029年までの世界予測 2025-03-07
• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07

MarketsandMarkets  出版レポート一覧